LINEBURG


<< . .

 83
( 87)



. . >>

6. Criswell, L. A., Merlino, L. A., Cerhan, J. R. et al. Cigarette smoking and the 33. Friedman, R. J., Schiff, C. F. & Bromberg, J. S. Use of supplemental steroids
risk of rheumatoid arthritis among postmenopausal women: results from in patients having orthopaedic operations. J. Bone Joint Surg. Am. 1995; 77:
the Iowa Women™s Health Study. Am. J. Med. 2002; 112: 465“71. 1801“6.
34. MacArthur, A. & Kleiman, S. Rheumatoid cervical joint disease: a challenge
7. Karlson, E. W., Mandl, L. A., Hankinson, S. E. & Grodstein, F. Do breast
feeding and other reproductive factors influence future risk of rheumatoid to the anaesthetist. Can. J. Anaesth. 1993; 40: 154“9.
arthritis? Results from the Nurses™ Health Study. Arthritis Rheum. 2004; 50: 35. Marks, J. D. & Bogetz, M. S. New concepts in the management of the diffi-
cult airway. Clin. Anesth. Update 1994; 5: 1“11
3458“67.
36. Conlon, P. W., Isdale, I. C. & Rose, B. S. Rheumatoid arthritis of the cervical
8. Spector, T. D., Hart, D. J. & Powell, R. J. Prevalence of rheumatoid arthritis
and rheumatoid factor in women: evidence of a secular decline. Ann. spine. An analysis of 333 cases. Ann. Rheum. Dis. 1966; 25: 120“6.
Rheum. Dis. 1993; 52: 254“7. 37. Neva, M. H., Isomaki, P., Hannonen, P. et al. Early and extensive erosiveness
in peripheral joints predicts atlantoaxial subluxations in patients with
9. Nelson, J. L. Rheumatoid arthritis. In Lee, R. V., Rosene-Montella, K,
Barbour, L. A., Garner, P. R. & Keely, E. (eds.), Medical Care of the Pregnant rheumatoid arthritis. J. Rheum. 2003; 48: 1808“13.
Patient. Philadelphia: American College of Physicians, 2000. 38. Fujiwara, K., Fujimoto, M., Owaki, H. et al. Cervical lesions related to the
10. Silman, A. J., Kay, A. & Brennan, P. Timing of pregnancy in relation to the systemic progression in rheumatoid arthritis. Spine 1998; 23: 2052“6.
39. Boden, S. D., Dodge, L. D., Bohlman, H. H. & Rechtine, G. R. Rheumatoid
onset of rheumatoid arthritis. Arthritis Rheum. 1992; 35: 152“5.
11. Nelson, J. L. & Ostensen, M. Pregnancy and rheumatoid arthritis. Rheum. arthritis of the cervical spine. A long term analysis with predictors of
Dis. Clin. North Am. 1997; 23: 195“212. paralysis and recovery. J. Bone Joint Surg. Am. 1993; 75: 1282“97.
12. Barrett, J. H., Brennan, P., Fiddler, M. & Silman, A. J. Does rheumatoid 40. Takenaka, I., Urakami, Y., Aoyama, K. et al. Severe subluxation in the
sniffing position in a rheumatoid patient with anterior atlantoaxial sub-
arthritis remit during pregnancy and relapse postpartum? Results from a
nationwide study in the United Kingdom prospectively from late preg- luxation. Anesthesiology 2004; 101: 1235“7.
nancy. Arthritis Rheum. 1999; 42: 1219“27. 41. Campbell, R. S. D., Wou, P. & Watt, I. A continuing role for preoperative
cervical spine radiography in rheumatoid arthritis? Clin. Radiol. 1995: 50:
13. Cecere, F. A. & Persellin, R. H. The interaction of pregnancy and the rheu-
157“9.
matoid diseases. Clin. Rheum. Dis. 1981; 7: 747“68.
14. Zurier, R. B. Pregnancy in patients with rheumatic diseases. Rheum. Dis. 42. Hale, J. M. & Moriarty, D C. Perioperative evaluation of the cervical spine
Clin. North Am. 1989; 15: 193“405. in rheumatoid arthritis using the dynamic magnetic resonance imaging.
Br. J. Anaesth. 2001; 86: 148“9.
15. Persellin, R. H. The effect of pregnancy on rheumatoid arthritis. Bull.
Rheum. Dis. 1976“1977; 27: 922“7. 43. Practical guidelines for the management of the difficult airway. An updated
16. Brennan, P. & Silman, A. J. Breast-feeding and the onset of rheumatoid report by the American Society of Anesthesiologists Task Force on
arthritis. Arthritis Rheum. 1994; 37; 808“13. Management of the Difficult Airway. Anesthesiology 2003; 98: 1269“77.
44. Wilson, M. E., Spiegelhalter, D., Robertson, J. A. & Lesser, P. Predicting
17. Brun, J. G., Nilssen, S. & Kvale, G. Breast-feeding, other reproductive factors
and rheumatoid arthritis: a prospective study. Br. J. Rheumatol. 1995; 34: difficult intubation. Br. J. Anaesth. 1988; 61: 211“16.
542“6. 45. Lofgren, R. H. & Montgomery, W. W. Incidence of laryngeal involvement in
rheumatoid arthritis. N. Engl. J. Med. 1962; 267: 193“5.
18. Klipple, G. L. & Cecere, F. A. Rheumatoid arthritis and pregnancy. Rheum.
46. Absalom, A. R., Watts, R. & Kong, A. Airway obstruction caused by rheuma-
Dis. Clin. North Am. 1989; 15: 213“39.
19. Yoshino, S. & Uchida, S. Sexual problems of women with rheumatoid toid cricoarytenoid arthritis. Lancet 1998; 351: 1099“100.
arthritis. Arch. Phys. Med. Rehabil. 1981; 62: 122“3. 47. Kolman, J. & Morris, I. Cricoarytenoid arthritis: a cause of acute upper
airway obstruction in rheumatoid arthritis. Can. J. Anesth. 2002; 49:
20. Branch, D. W. Pregnancy in patients with rheumatic diseases: obstetric
management and monitoring. Lupus 2004; 13: 696“8. 729“32.
21. Kaplan, D. & Diamond, H. Rheumatoid arthritis and pregnancy. Clin. 48. Popat, M. T., Chippa, J. H. & Russell, R. Awake fibreoptic intubation follow-
Obstet. Gynecol. 1965; 8: 286“303. ing failed regional anaesthesia for Caesarean section in a parturient with
Still™s disease. Eur. J. Anaesthesiol. 2002; 17: 211“14.
22. Janssen, N. M. & Genta, M. S. The effects of immunosuppressive and anti-
inflammatory medications on fertility, pregnancy and lactation. Arch. 49. Creed, F. & Ash, D. Depression in rheumatoid arthritis: aetiology and treat-
Intern. Med. 2000; 160: 610“19. ment. Int. Rev. Psychiatry 1992; 4: 23“34.




420
Chapter 23


50. Lahita, R. G. The role of sex hormones in systemic lupus erythematosus. 76. Buyon, J. P. Neonatal lupus syndromes. Curr. Opin. Rheumatol. 1994; 6:
Curr. Opin. Rheumatol. 1999; 11: 352“6. 523“9.
51. Tan, E. M., Cohen, A. S., Fries, J. F. et al. The 1982 revised criteria for the 77. Lee, L. A. Maternal autoantibodies and pregnancy“II: the neonatal lupus
classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: syndrome. Baillieres Clin. Rheumatol. 1990; 4: 69“84.
1271“7. 78. McCune, A. B., Weston, W. L. & Lee, L. A Maternal and fetal outcome in
52. Hochberg, M. C. Updating the American College of Rheumatology revised neonatal lupus erythematosus. Ann. Intern. Med. 1987; 106: 518“23.
criteria for the classification of systemic lupus erythematosus. Arthritis 79. Cimaz, R., Spence, D. L., Hornberger, L. & Silverman, E. D. Incidence
Rheum. 1997; 40: 1725. and spectrum of neonatal lupus erythematosus: a prospective study of
53. Friedman, S. A., Bernstein, M. S. & Kitzmiller, J. L. Pregnancy complicated infants born to mothers with anti-Ro autoantibodies. J. Pediatr. 2003; 142:
by collagen vascular disease. Obstet. Gynecol. Clin. North Am. 1991; 18: 678“83.
213“36. 80. Jaeggi, E. T., Hamilton, R. M., Silverman, E. D., Zamoras, A. & Hornberger,
54. Toloza, S. M., Roseman, J. M., Alarcon, G. S. et al. Systemic lupus erythe- L. K. Outcome of children with fetal, neonatal or childhood diagnosis of
matosus in a multiethnic US cohort (LUMINA): XXII: Predictors of time isolated congenital atrioventricular block. A single institution™s experience
to the occurrence of the initial damage. Arthritis Rheum. 2004; 50: of 30 years. J. Am. Coll. Cardiol. 2002; 39: 130“7.
3177“86. 81. Rosenthal, D., Druzin, M., Chin, C. et al. A new therapeutic approach to the
55. Stoll, T., Sutcliffe, N., Mach, J. et al. Analysis of the relationship between fetus with congenital complete heart block: preemptive targeted therapy
disease activity and damage in patients with systemic lupus erythematosus “ with dexamethasone. Obstet. Gynecol. 1998; 92: 689“91.
a 5 year prospective study. Rheumatology 2004; 43: 1039“44. 82. Riuz-Irastorza, G. & Khamashta, M. A. Evaluation of systemic lupus erythe-
56. Swaak, A. J., Nossent, J. C. & Smeenk, R. J. Prognostic factors in systemic matosus activity during pregnancy. Lupus 2004; 13: 679“82.
lupus erythematosus. Rheumatol. Int. 1991; 11: 127“32. 83. Walz LeBlanc, B. A., Gladman, D. D. & Urowitz, M. B. Serologically active
57. Tincani, A., Balestrieri, G., Faden, D. & DiMario, C. Systemic lupus erythe- clinically quiescent systemic lupus erythematosus predictors of clinical
matosus in pregnancy. Lancet 1991; 338: 756“7. flares. J. Rheumatol. 1994; 21: 2239“41.
58. Petri, M., Howard, D. & Repke, J. Frequency of lupus flare in pregnancy: The 84. Petri, M. Systemic lupus erythematosus: women™s health care issues. Bull.
Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 1991; 34: Rheum. Dis. 2001; 49: 1“3.
1538“45. 85. Mandell, B. F. Cardiovascular involvement in systemic lupus erythemato-
59. Riuz-Irastorza, G., Lima, F. & Alves, J. et al. Increased rate of lupus flare sus. Semin. Arthritis Rheum. 1987; 17: 126“41.
during pregnancy: a prospective study of 78 pregnancies. Br. J. Rheumatol. 86. Nihoyannopoulos, P., Gomez, P. M., Joshi, J. et al. Cardiac abnormalities in
1996; 35: 133“8. systemic lupus erythematosus. Association with raised anticardiolipin
60. Urowitz, M. B., Gladman, D. D. & Farewell, V. T. et al. Lupus and pregnancy abnormalities. Circulation 1990; 82: 369“75.
studies. Arthritis Rheum. 1993; 36: 1392“7. 87. Roldan, C. A., Shively, B. K. & Crawford, M. H. An echocardiographic study
61. Georgiou, P. E., Politi, E. N., Katsimbri, P., Sakka, V. & Drosos, A. A. Outcome of valvular heart disease associated with systemic lupus erythematosus.
of lupus pregnancy: a controlled study. Rheumatology 2000; 39: 1014“19. N. Engl. J. Med. 1996; 335: 1424“30.
62. Molad, Y., Borkowski, T., Monselise, A. et al. Maternal and fetal outcome of 88. Carette, S. Cardiopulmonary manifestations of systemic lupus erythema-
lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005; 14: tosus. Rheum. Dis. Clin. North Am. 1988; 14: 135“47.
145“51. 89. Petri, M., Perez-Gutthann, S., Spence, D. & Hochberg, M. C. Risk factors for
63. Hayslett, J. P. Maternal and fetal complications in pregnant women with coronary artery disease in patients with systemic lupus erythematosus.
systemic lupus erythematosus. Am. J. Kidney Dis. 1991; 17: 123“6. Am. J. Med. 1992; 93: 513“19.
64. Varner, M. W. Autoimmune disorders and pregnancy. Semin. Perinatol. 90. Robinson, D. R. Systemic lupus erythematosus. In Dale, D. C.,
1991; 15: 238“50. Federman, D. D., Antman, K. et al. (eds.), Scientific American Medicine,
65. Julkunen, H., Kaaja, R., Palosuo, T., Gronhagen-Riska, C. & Teramo, K. Vol. 2. New York: WedMD Professional Publishing, 1999.
Pregnancy in lupus nephropathy. Acta Obstet. Gynecol. Scand. 1993: 72: 91. Omdal, R., Henriksen, O. A., Mellgren, S. I. & Husby, G. Peripheral neuro-
258“63. pathy in systemic lupus erythematosus. Neurology 1991; 41: 808“11.
66. Khamashta, M. A. & Hughes, G. R. V. Pregnancy in systemic lupus erythe- 92. Mikdashi, J., Krumholz, A. & Handwerger, B. Factors at diagnosis predict
matosus. Curr. Opin. Rheumatol. 1996; 8: 424“9. subsequent occurrence of seizures in systemic lupus erythematosus.
67. Mok, C. C. & Wong, R. W. S. Pregnancy in systemic lupus erythematosus. Neurology 2005; 64: 2102“7.
Postgrad. Med. J. 2001; 77: 157“65. 93. Winslow, T. M., Ossipov, M. A., Fazio, G. P. et al. Five year follow-up study
68. Mok, C. C., Lau, C. S. & Wong, R. W. S. Risk factors or ovarian failure in of the prevalence and progression of pulmonary hypertension in systemic
patients with systemic lupus erythematosus receiving cyclophosphamide lupus erythematosus. Am. Heart J. 1995; 129: 510“15.
therapy. Arthritis Rheum. 1998; 41: 831“7. 94. Cuenco, J., Tzeng, G. & Wittels, B. Anesthetic management of the parturi-
69. Chakravarty, E. F., Colon, I., Langen, E. S. et al. Factors that predict prema- ent with systemic lupus erythematosus, pulmonary hypertension and
turity and pre-eclampsia in pregnancies that are complicated by systemic pulmonary edema. Anesthesiology 1999; 91: 568“70.
lupus erythematosus. Am. J. Obstet. Gynecol. 2005; 192: 1897“904. 95. Keeling, D. M. & Isenberg, D. A. Haematological manifestations of SLE.
70. Raj, R., Murin, S., Matthay, R. A. & Wiedemann, H. P. Systemic lupus erythe- Blood Rev. 1993; 7: 199“207.
matosus in the intensive care. Crit. Care Clin. 2002; 18: 781“803. 96. Pitkin, R. M. Polyarteritis nodosa. Clin. Obstet. Gynecol. 1983; 26: 579“86.
71. Keane, M. P., Van De Ven, C. J. M., Lynch III, J. P. & McCune, W. J. Systemic 97. Carpenter, M. T. & West, S. G. Polyarteritis nodosa in hairy cell leukaemia:
lupus during pregnancy with refractory alveolar haemorrhage: recovery treatment with interferon-alpha. J. Rheumatol. 1994; 21: 1150“2.
following termination during pregnancy. Lupus 1997; 6: 730“3. 98. Guillevin, L., Lhote, F., Cohen, P. et al. Polyarteritis nodosa related hepa-
72. Melk, A., Mueller-Eckhardt, G., Polten, B. et al. Diagnostic and prognostic titis B virus. A prospective study with short term observation of 41 patients.
significance of anticardiolipin antibodies in patients with recurrent spon- Medicine 1995; 74: 238“53.
taneous abortions. Am. J. Reprod. Immunol. 1995; 33: 228“33. 99. Lhote, F. & Guillevin, L. Polyarteritis nodosa, microscopic polyangiitis, and
73. Clowse, M. E. B., Magder, L. S., Witter, F. & Petri, M. The impact of increased Churg-Strauss syndrome. Clinical aspects and treatment. Rheum. Dis.
lupus activity on obstetric outcomes. Arthritis Rheum. 2005; 52: 514“21. Clin. North Am. 1995; 21: 911“43.
74. Petri, M. Prospective study of systemic lupus erythematosus pregnancies. 100. Lightfoot, R. W., Michet, B. A., Bloch, D. A. et al. The American College of
Lupus 2004; 13: 688“9. Rheumatology 1990 criteria for the classification of polyarteritis nodosa.
75. Ross, G., Nas, R. & Lockshin, M. Effects of mothers™ autoimmune disease Arthritis Rheum. 1990; 33: 1088“93.
during pregnancy on learning disabilities and hand preference in children. 101. Gayraud, M., Guillevin, L., le Toumelin, P. et al. Long term follow up of
Arch. Pediatr. Adolesc. Med. 2003; 157: 397“402. polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss




421
5 Other disorders


syndrome. analysis of four prospective trials including 278 patients. 127. Bailey, A. R., Wolmarans, M. & Rhodes, S. Spinal anaesthesia for caesarean
Arthritis Rheum. 2001; 44: 666“75. section in a patient with systemic sclerosis. Anaesthesia 1999; 54: 355“8.
102. Guillevin, L., Cohen, P., Mahr, A. et al. Treatment of polyarteritis nodosa 128. Lewis, G. B. Prolonged regional analgesia in scleroderma. Can. Anaesth.
and microscopic polyangiitis with poor prognostic factors: a prospective Soc. J. 1974; 21: 495“7.
trial comparing glucocorticoids and six or twelve cyclophosphamide 129. Neill, R. S. Progressive systemic sclerosis. Prolonged sensory blockade
pulses in sixty-five patients. Arthritis Rheum. 2003; 49: 93“100. following regional anaesthesia in association with a reduced response to
103. Frohnert, P. P. & Sheps, S. G. Long term follow up study of periarteritis systemic analgesics. Br. J. Anaesth. 1980; 52: 623“5.
nodosa. Am. J. Med. 1967; 43: 8“14. 130. Hseu, S. S., Sung, C. S., Mao, C. C., Tsai, S. K. & Lee, T. K. Anesthetic man-
104. Guillevin, L., Lhote, F., Gayraud, M. et al. Prognostic features in polyarter- agement in a parturient with progressive systemic sclerosis during caesar-
itis nodosa and Churg-Strauss syndrome. A prospective study in 342 ean section “ a case report. Acta Anaesthesiol. Sin. 1997; 35: 161“6.
patients. Medicine 1996; 75: 17“28. 131. D™Angelo, R. & Miller, R. Pregnancy complicated by severe preeclampsia
105. Ramsey-Goldman, R. The effect of pregnancy on the vasculitides. Scand. J. and thrombocytopenia in a patient with scleroderma. Anesth. Analg. 1997;
Rheumatol. Suppl. 1998; 107: 116“17. 85: 839“41.
106. Stone, M. S., Olson, R. R., Weismann, D. N. et al. Cutaneous vasculitis in 132. Sammaritano, L. R. Antiphospholipid syndrome: review. South. Med. J.
the newborn of a mother with cutaneous polyarteritis nodosa. J. Am. Acad. 2005; 98: 617“25.
Dermatol. 1993; 28: 101“5. 133. Cervera, R., Piette, J. C., Font, J. et al. Antiphospholipid syndrome: clinical
107. Black, C. M. Scleroderma-clinical aspects. J. Intern. Med. 1993; 234: and immunological manifestation and patterns of disease expression in a
115“18. cohort of 1000 patients. Arthritis Rheum. 2002; 46: 1019“27.
108. Anonymous. Systemic sclerosis: current pathogenetic concepts and future 134. Carp, H. J. A. Antiphospholipid syndrome in pregnancy. Curr. Opin.
prospects for target therapy. Lancet 1996; 347: 1453“8. Obstet. Gynecol. 2004; 16: 129“35.
109. Janosik, D. L., Osborn, T. G., Moore, T. L. et al. Heart disease in systemic 135. Sebastiani, G. D., Galeazzi, M., Tincani, A. et al. Anticardiolipin and
sclerosis. Semin. Arthritis Rheum. 1989; 19: 191“200. anti“beta2GPI antibodies in a large series of European patients with sys-
110. Seibold, J. R., Korn, J. H., Simms, R. et al. Recombinant human relaxin in temic lupus erythematosus. Prevalence and clinical associations.
the treatment of scleroderma. Ann. Intern. Med. 2000; 132: 871“9. European concerted action on immunogenetics of SLE. Scand. J.
111. Ferri, C., Valentini, G., Cozzi, F. et al. Systemic sclerosis: demographic, Rheumatol. 1999; 28: 344“51.
clinical and serologic features and survival in 1,012 Italian patients. 136. Sammaritano, L. R., Ng, S., Sobel, R. et al. Anticardiolipin IgG subclasses.
Medicine 2002; 81: 139“53. Association of IgG2 with arterial and/or venous thrombosis. Arthritis
112. Scussel-Lonzetti, L., Joyal, F., Raynauld, J. P. et al. Predicting mortality in Rheum. 1997; 40: 1998“2006.
systemic sclerosis: analysis of a cohort of 309 French Canadian patients 137. Parke, A. Short and long term maternal outcomes in patients with phos-
with emphasis on features at diagnosis as predictive factors for survival. pholipid antibodies. Lupus 2004; 13: 703“4.
Medicine 2002; 81: 154“67. 138. Erkan, D., Asherson, R. A., Espinosa, G. et al. Long term outcome of cata-
113. Rothfield, N., Kurtzman, S., Vazquez“Abad, D. et al. Association of anti- strophic syndrome survivors. Ann. Rheum. Dis. 2003; 62: 530“3.
topoisomerase I with cancer. Arthritis Rheum. 1992; 35: 724. 139. Asherson, R. A., Cervera, R., Piette, J. C. et al. Catastrophic antiphospholi-
114. Englert, H., Brennan, P., McNeil, D. et al. Reproductive function prior to pid syndrome: clinical and laboratory features of 50 patients. Medicine
disease onset in women with scleroderma. J. Rheumatol. 1992; 19: 1575“9. 1998; 77: 195“207.
115. Steen, V. D., Conte, C., Day, N. et al. Pregnancy in women with systemic 140. Kutteh, W. H. Antiphospholipid antibodies and reproduction. J. Reprod.
sclerosis. Arthritis Rheum. 1989; 32: 151“7. Immunol. 1997; 35: 151“71.
116. Chin, K. A. J., Kaseba, C. M. & Weaver, J. B. Scleroderma in pregnancy. J. 141. Vinatier, D., Dufour, P., Cosson, M. et al. Antiphospholipid syndrome and
Obstet. Gynaecol. 1998; 18: 238“42. recurrent miscarriages. Eur. J. Obst. Gynecol. Reprod. Biol. 2001; 96: 37“50.
117. Steen, V. D. Pregnancy in women with systemic sclerosis. Obstet. Gynecol. 142. Blank, M. & Shoenfeld, Y. Antiphosphatidylserine antibodies and repro-
1999; 94: 15“20. ductive failure. Lupus 2004; 13: 731“5.
118. Steen, V. D. Scleroderma and pregnancy. Rheum. Dis. Clin. North Am. 143. Branch, D. W. Antiphospholipid antibodies and fetal compromise.
1997; 23: 133“47. Thrombosis Research 2004; 114: 415“18.
119. Baethge, B. A. & Wolf, R. E. Successful pregnancy with scleroderma renal 144. Derksen, R. H. W. M., Khamashta, M. A. & Branch, D. W. Management of the
disease and pulmonary hypertension in a patient using angiotensin con- obstetric antiphospholipid syndrome. Arthritis Rheum. 2004; 50: 1028“39.
verting enzyme inhibitors. Ann. Rheum. Dis. 1989; 48: 776“8. 145. Lassere, M. & Empson, M. Treatment of antiphospholipid syndrome in
120. Silman, A. J. & Black, C. Increased incidence of spontaneous abortion and pregnancy “ a systematic review of randomized therapeutic trials.
infertility in women with scleroderma before disease onset: a case con- Thrombosis Research 2004; 114: 419“26.
trolled study. Ann. Rheum. Dis. 1988; 47: 441“4. 146. Ringrose, D. K. Anaesthesia and the antiphospholipid syndrome: a review
121. Steen, V. D. & Medsger, T. A. Fertility and pregnancy outcome in women of 20 obstetric patients. Int. J. Obstet. Anesth. 1997; 6: 107“11.
with systemic sclerosis. Arthritis Rheum. 1999; 42: 763“8. 147. Ralph, C. J. Anaesthetic management of parturients with the antiphospho-
122. Moore, M., Saffran, J. E., Baraf, H. S. & Jacobs, R. P. Systemic sclerosis and lipid syndrome: a review of 27 cases. Int. J. Obstet. Anesth. 1999; 8: 249“52.
pregnancy complicated by obstructive uropathy. Am. J. Obstet. Gynecol. 148. Rawat, R. S. & Dehran, M. Anaesthetic management of a pregnant patient
1985; 153: 893“4. with antiphospholipid antibody syndrome for emergency caesarean sec-
123. Bellucci, M. J., Coustan, D. R. & Plotz, R. D. Cervical scleroderma: a case of tion. Int. J. Obstet. Anesth. 2003; 12: 311.
soft tissue dystocia. Am. J. Obstet. Gynecol. 1984; 150: 891“2. 149. Ihle, B. U. & Oziemski, P. Multiorgan failure secondary to catastrophic
124. Thompson, J. & Conklin, K. A. Anesthetic management of a pregnant anti-phospholipid syndrome. Anaesth. Intensive Care 2002; 30: 82“5.
patient with scleroderma. Anesthesiology 1983; 59: 69“71. 150. Dorman, R. I. P. Acute postoperative biventricular failure associated with
125. Younker, D. & Harrison, B. Scleroderma and pregnancy: anaesthetic con- antiphospholipid antibody syndrome. Br. J. Anaesth. 2004; 92: 748“54.
siderations. Br. J. Anaesth. 1985; 57: 1136“9. 151. Ozaki, M., Ogata, M., Yokoyama, T. et al. Prevention of thrombosis with
126. Eisele, J. H. & Reitan, J. A. Scleroderma, Raynaud™s phenomenon, and local prostaglandin E1 in a patient with catastrophic antiphospholipid syn-
anesthesics. Anesthesiology 1971; 34: 386“7. drome. Can. J. Anesth. 2005; 52: 143“7.




422
INDEX




As the subject of this book is obstetric anesthesiology, all entries relate to this unless specifically stated.

ABCDE markings, malignant melanoma, 351 acoustic neuromas, 173 AFE see amniotic fluid embolism (AFE)
abdominal dimensions, dwarfism, 103, 116 epidemiology, 375 afibrinogenemia, 310
abdominal radical trachelectomy, 373 pregnancy effects, 173 management, 310
abducent (VI) nerve acquired atrioventricular blocks, 33 AFLP see acute fatty liver of pregnancy
cranial nerve lesions, 219 acquired factor VIII deficiency, 312 (AFLP)
nerve palsy, 179 acquired Glanzmann thrombasthenia, 306 afterload reduction
ACAD, heart transplantation, 387 acquired hemolytic anemias, 296 peripartum cardiomyopathy, 11
accelerated atherosclerosis (ACAD), heart acquired long QT syndrome see long QT primary pulmonary hypertension, 58
transplantation, 387 syndrome (LQTS) AIDS see HIV infection
acetaminophen acromegaly, 281 air filters, 22
back pain therapy, 231 actinomycin D, 376 airway evaluation/management
dosage, 232 Actinomycosis israeli infection, 322 achondroplasia, 119
renal failure effects, 261 activated partial thromboplastin time (aPTT) arthrogryposis multiplex congenita, 158
migraine therapy, 230 anticoagulation therapy, 4 diabetes mellitus, 280
post cesarean section pain, 235 deep vein thrombosis management, 82 Marfan syndrome, 68“9
achondroplasia, 101, 118“20 pregnancy, effects of, 293, 384 osteogenesis imperfecta, 163
airway management, 119 activated protein C resistance, 314 rheumatoid arthritis, 408
anesthetic management, 103, 122“5 thromboembolic disease, 81 scleroderma, 418
dosages, 110, 123 acute asthma see asthma scoliosis, 140
general anesthesia see below acute cardiac decompensation see scoliosis thyrotoxic crisis, 276
noninvasive monitoring, 122 acute dysrhythmias, 30 alanine aminotransferase (ALT)
postoperative pain management, 124“5 acute fatty liver of pregnancy (AFLP), 249, 251, liver transplantation, 384
regional anesthesia see below 253“5, 308 pregnancy, effects of, 249, 250, 258, 384
characteristics, 104, 108, 118 acute intermittent porphyria (AIP), 242 albendazole, 257
cor pulmonale, 110, 120 acute liver failure see liver failure albumin (serum)
craniofacial features, 108, 119 acute narrow complex tachycardia, 51 globulin ratio, 384
foramen magnum stenosis, 108, 110, 119“20, 120 acute Trypanosoma cruzi infection, 333 pregnancy, effects of, 249, 250, 255, 384
hydrocephalus, 120 acute tubular necrosis (ATN), 259 albuterol, 79
hypotonia, 120 acyclovir, 249, 262 alcohol abuse, 224
pelvic measurements, 120 acyl-CoA dehydrogenase deficiency, 254 alcoholic ketoacidosis, 279
spinal canal narrowing, 108, 119“20 Addison disease, 285“6 alfentanil
spinal features, 108, 119, 120 Addisonian crisis, 286 pheochromocytoma, 284
diagnosis, 119 circulatory collapse, 286 renal failure effects, 261
general anesthesia, 122 adenosine, 51, 52 alkaline phosphatase (ALP), pregnancy, effects of,
direct laryngoscopy, 122 acute narrow complex tachycardia, 51 249, 250, 257“8, 384
endotracheal tube size, 110, 122 adverse maternal effects, 51 allergic purpura, 309
fiberoptic laryngoscopy, 122 primary pulmonary hypertension, 58 ALP see alkaline phosphatase (ALP)
intubation, 110, 122 safety, 51 a2-adrenergic agonists, 233, 234
incidence, 115, 118 supraventricular tachycardias, 36 alpha-blockers
kyphoscoliosis, 120 tachydysrhythmia therapy, 36 pheochromocytoma management, 284
neurologic symptoms, 120 wide-complex tachycardia, 51 renal failure effects, 261
regional anesthesia, 108, 110, 119, 120, 122“3 adjuvant chemotherapy, ovarian cancer, 374 adSPD, 306
combined spinal“epidural analgesia/ adolescent idiopathic scoliosis (ASIS), 129 alpha thalassemia, 294, 295
anesthesia, 124 adrenal gland disorders, 283“8 Alport syndrome, 250, 263“4
continuous regional, 123 see also specific diseases/disorders alprazolam, 369
continuous spinal, 124 adult respiratory distress syndrome (ARDS), 75“7, 395 ALT see alanine aminotransferase (ALT)
epidural analgesia/anesthesia, 104, 123 nitric oxide, 76, 93 alveolar hypertension, scoliosis, 133
neuraxial anesthesia, 120 positive pressure ventilation, 75“6 alveoli numbers, scoliosis, 132
single-shot spinal, 123“4 Advanced Cardiac Life Support (ACLS) amantadine, 171
respiratory complications, 108, 120 bradycardia algorithm, 32 AMC see arthrogryposis multiplex
infections, 120 supraventricular tachycardias management, 36 congenita (AMC)
upper airway obstruction, 110, 120 Advisory Committee on Immunizations American College of Cardiology, 10
acitretin, 349 Practices, yellow fever vaccine American College of Obstetricians and
ACLS see Advanced Cardiac Life Support (ACLS) recommendations, 329 Gynecologist, 193




423
Index


American Society of Regional Anesthesia (ASRA), 5 anterior spinal artery syndrome (ASAS), 207“9 pregnancy, effects on, 168“9
spinal hematoma guidelines, 176 anthelmintics, 257 side effects, 170
thromboembolic disease guidelines, 85 antiacetylcholine antibody assay, 152 antihypertensive drugs
American Spinal Injury Association, 191 antibiotic therapy Conn syndrome, 287
amide local anesthetics, epileptic effects, 170 bacterial infections, 321 intravenous fluid management, 180
amino acid metabolism disorders, 240, 241 cystic fibrosis therapy, 90 anti-inflammatory drugs, adult respiratory distress
see also specific diseases/disorders drug interactions, cyclosporine, 392 syndrome, 76
aminolevulinate dehydratase deficiency gastrointestinal procedures, 5 antimalarial drugs, systemic lupus erythematosus
porphyria, 242 genitourinary procedures, 5 therapy, 412
amiodarone, 39, 52 heart disease, 4 antinuclear antibodies, systemic lupus
acquired long QT syndrome, 46 infective endocarditis, 4 erythematosus, 410
atrial fibrillation therapy, 38 Marfan syndrome, 67 antiparkinsonian agents, schizophrenia, 363
peripheral neuropathy, 224 meningitis, 335 antiphospholipid antibodies, 303, 314
pre-excitation syndrome therapy, 43 mitral stenosis, 7 thrombocytopenia, 305
supraventricular tachycardias, 36 anticholinergic drugs, status asthmaticus antiphospholipid syndrome, 418“19
tachydysrhythmia therapy, 36 management, 79 assessment, 416
thyroid disease effects, 277 anticholinesterase drugs case reports, 405, 416, 419
amitriptyline dosages, 154 autoantibodies, 418
dosages, 232 myasthenia gravis therapy, 152“3, 154, 155 cesarean section, 419
post cesarean section pain therapy, 235 anticipation, congenital myotonic dystrophy, 103 clinical features, 418
amniotic fluid embolism (AFE), 85, 86“8 anticoagulant therapy heparin therapy, 419
amoxicillin, 5 activated partial thromboplastin time, 4 management, 419
Vibrio cholerae therapy, 333 atrial fibrillation, 38 mortality, 419
ampicillin, 5 cerebral ischemia, 177 Sneddon syndrome, 352
amyotrophic lateral sclerosis (ALS), 198“201 heart disease, 4“6 antipsychotic drugs
analgesia homocystinuria, 242 interactions, 364
adult respiratory distress syndrome, 77 mitral stenosis, 7 during pregnancy, 364
atrial septal defects, 17 Moyamoya disease management, 69 antiretroviral therapy, HIV mother“child
bone marrow failure syndromes, 299 peripartum cardiomyopathy, 11 transmission, 323
hepatic function effects, 255 peripartum ischemic heart disease, 15 antithrombin III, pregnancy, effects of, 294
liver transplantation, anesthetic primary pulmonary hypertension, 58 antithrombin deficiency, 314
management, 394 Takayasu arteritis, 65 antithymocyte globulin (ATG), 322, 389
peripartum ischemic heart disease, 15 see also specific drugs antiviral therapy, varicella zoster virus infection, 326
pheochromocytoma, 284 anticonvulsant drugs anxiolysis, pheochromocytoma, 284
postoperative central nervous system tumor therapy, 375, 376 aorta, coarctation of see coarctation of the aorta
achondroplasia, 124“5 post cesarean section pain therapy, 235 aortic balloon valvuloplasty, aortic stenosis, 8
post cesarean section, 234 antidepressant drugs aortic dissection, 13“14, 67
spinal cord injury, 193 fibromyalgia therapy, 233 Marfan syndrome see Marfan syndrome (MFS)
anemias, 293“7 post cesarean section pain therapy, 235 aortic heart disease, 40
peripartum ischemic heart disease, 14 antiDNA antibodies, systemic lupus aortic insufficiency see aortic regurgitation/
see also specific diseases/disorders erythematosus, 410 insufficiency
anesthesia antidromic AV reentrant tachycardia, 43 aortic regurgitation/insufficiency, 9
cardiovascular effects, 2 antidysrhythmic drugs, 49“52 aortic root dilatation, Marfan syndrome, 65“6
drug interactions acquired long QT syndrome, 46 aortic stenosis, 8“9, 20
cyclosporine, 392 atrial septal defect management, 17 aortic valve
monoamine oxidase inhibitors, 367 breast milk secretion, 51 replacement, complications, 10
see also specific agents; specific diseases/disorders; class Ia, 46 size, aortic stenosis, 8
specific types class III, 46 aortocaval compression, 1
aneurysms, 57 dosage, 49 apheresis, 293
angina renal failure effects, 261 aplastic anemia, 297“8
paroxysmal supraventricular tachycardia, 36 FDA grading, 51, 52 aPTT see activated partial thromboplastin time
primary pulmonary hypertension, 57 mitral valve prolapse, 10 (aPTT)
angioedema, hereditary, 353 placental transfer, 51 ARDS see adult respiratory distress syndrome
angiography premature ventricular depolarization (ARDS)
central nervous system disorders, 167 management, 34 L-arginine, Eisenmenger syndrome
Moyamoya disease, 69 tachydysrhythmia therapy, 36 management, 22
pulmonary arteriovenous malformations, 60, 61 teratogenicity, 51 Arnold Chiari malformation, 183“5
angiomas, 196 ventricular tachycardia therapy, 39 arrhythmogenic right ventricular cardiomyopathy
animal models, malignant hyperthermia, 269 see also specific drugs (ARVC), 35
anion gap acidosis, 279 antiemetic drugs, hyperemesis gravidarum implantable cardiac defibrillator, 53
antenatal assessment, transplantation, 393 management, 252 arsenic, peripheral neuropathy, 223
antenatal diagnosis, osteogenesis imperfecta, 162 antiepileptic drugs (AEDs) arterial blood gas analysis, 77
antepartum assessment anesthesia interactions, 169 arterial cannulation, acute fatty liver of
scoliosis see scoliosis breast milk, excretion in, 169 pregnancy, 255
spinal cord injury, 193 congenital malformations, 167, 169 arterial hypertension, liver transplantation, 386
anterior sacral meningocele, spina bifida minimal dose, 169 arterial lines, congenital heart disease, 15
cystica, 204 pregnancy, effects of, 169 arterial occlusion, cerebral ischemia, 177




424
Index


arterial oxygen, scoliosis, 135 autoimmune hemolytic anemias, 297 porphyria, 245
arteriovenous malformations (AVMs), 57 autoimmune hepatitis, 249, 257 portal hypertension, 255
hereditary hemorrhagic telangiectasia, 309 autoimmune progesterone dermatitis, 353 premature ventricular depolarization, 34
spinal cord tumors, 196 automated internal cardiac defibrillators renal failure effects, 261
arthritis, systemic lupus erythematosus, 410 (AICD), 46“7 spinal cord injury, 194
arthrochalasia, Ehlers Danlos syndrome, 159 autonomic function, diabetic neuropathy, 221 tachydysrhythmia, 36
arthrogryposis multiplex congenita (AMC), autonomic hyperreflexia (AH), 193“4 Takayasu arteritis, 65
157“9, 269, 271 autosomal dominant polycystic kidney disease beta lactams, 333
ASAS see anterior spinal artery syndrome (ASAS) (ADPKD), 250, 262“3 beta-mimetic tocolytics, 192
aseptic techniques, transplant recipients, 393 autotransfusion, 1 beta thalassemias, 294, 295
heart“lung transplants, 382“3 AVMs see arteriovenous malformations (AVMs) bicarbonate replacement, diabetic ketoacidosis, 279
heart transplants, 382“3 azathioprine, 389, 392, 395 bile acids, pregnancy, effects of, 250
aspartate aminotransferase (AST) myasthenia gravis therapy, 152, 153 bilevel positive airway pressure (BiPap), 201
liver transplantation, 384 peripartum cardiomyopathy, 11 bilharzia see schistosomiasis
pregnancy, effects of, 249, 250, 258, 384 rheumatoid arthritis therapy, 407, 408 biliary tract disease, 258
aspiration risk, scleroderma, 418 azithromycin, 333 bilirubin, pregnancy, effects of, 249, 250, 257, 384
aspirin biologic agents, dermatoses, 353
American Society of Regional Anesthesiology back pain, 141, 230“1 bipolar disorder see manic depressive illness
guidelines, 5 baclofen, 192 birthweight, cyclosporine effects, 391
antiphospholipid syndrome, 419 bacterial endocarditis bisphosphonates, hyperparathyroidism
essential thrombocytopenia, 300 mitral valve prolapse, 10 management, 288
Moyamoya disease management, 69 prophylaxis see congenital heart disease (CHD) Blalock“Taussig shunt, 21, 29, 52
rheumatoid arthritis therapy, 407 bacterial infections, 321“3, 389 blood disorders, 293“320
ASRA see American Society of Regional Anesthesia dermatoses, 353, 356 see also specific diseases/disorders
(ASRA) pregnancy in kidney transplantation, 383 blood pressure
AST see aspartate aminotransferase (AST) see also specific infections/bacteria Cushing syndrome, 287
asthma, 36, 77“80 Bacteroides bivius infection, 322 heart transplantation, anesthetic
astrocytomas, 195 balloon dilation, 94 management, 396
ataxia-telangiectasia, pheochromocytoma, 283 balloon embolization, 61 pregnancy, effects of, 1
ataxic gait, 156 balloon mitral valvuloplasty, 7 blood transfusions see transfusions
ateliotic dwarfism, 104, 115 barbiturates blood volume, pregnancy, effects of, 294
atenolol, dosages, 232 HIV infection, 324 b-mimetic tocolytics, Ehlers Danlos syndrome, 160
ATN see acute tubular necrosis (ATN) side effects, 170 bone fragility, osteogenesis imperfecta, 161
atracurium Bartonella, 257 bone marrow abnormalities, 297“302
acute fatty liver of pregnancy, 255 Bartter syndrome, 250, 264 see also specific diseases/disorders
cardiovascular effects, 2 clinical features, 264 bone marrow transplantation, 302“3
myasthenia gravis, 155 basiliximab, 389 Borgschulte“Grigsby deficiency, 314
renal failure effects, 261 Becker muscular dystrophy, 101 Bourneville“Pringle disease see tuberous sclerosis
atrial dysrhythmias, hypertrophic obstructive beclomethasone, 78 brachial amyotrophic diplegia, 200
cardiomyopathy management, 12 behavioral interventions, migraine, 230 brachial arterial catheterization, 418
atrial fibrillation, 35, 37“8, 42, 44 benign intracranial hypertension, 177“8 brachial nerve palsy, 219
Noonan syndrome, 147 benzhexol, 363 bradycardias, management, 33“4
atrial flutter, 34, 35, 36“7 benzodiazepines bradydysrhythmias
atrial septal defects, 16“17, 29 breast milk, secretion in, 169 long QT syndrome, 46
atrial switch, 21, 30“2 chronic spinal cord injury management, 192 pacemakers, 49
atrial tachycardia, 35, 36“7 cyclosporine interactions, 392 brain abscesses, pulmonary arteriovenous
atrioventricular (AV) blocks, 30, 32“3, 49 fetal effects, 369 malformations, 62
atrioventricular junctional dysrhythmias, 30 HIV infection, 324 brain death, coma, 182“3
atrioventricular node reentrant (AVNRT) panic disorder management, 369 brain protection, neurosurgery, 180

<< . .

 83
( 87)



. . >>

Copyright Design by: Sunlight webdesign